title: Cardiovascular Imaging with PET, CT, and MR Imaging.
abstract: PET provides high-resolution images of radiopharmaceutical biodistribution in vivo. Fluorine-18-labeled fluorodeoxyglucose (FDG)-PET is an established entity in the work-up of several oncologic disorders and is making forays in the diagnosis of inflammatory diseases, leading to increased use for cardiac and neurologic applications. Combined myocardial perfusion and metabolism imaging using FDG-PET is the gold standard for noninvasive assessment of myocardial viability. Advances in imaging instrumentation (including CT and MR imaging technology) facilitate noninvasive assessment of cardiovascular pathologies. MR imaging is best placed to provide the most comprehensive cardiac evaluation. This article addresses evaluation of the cardiovascular system by PET, CT, and MR imaging.
authors.affiliation: PET Imaging Center, Biomedical Research Foundation of Northwest Louisiana, 1505 Kings Highway, Shreveport, LA 71103, USA; Department of Radiology, LSUHSC-S, 1501 Kings Highway, Shreveport, LA 71103, USA. Electronic address: amoltakalkar@yahoo.com.
authors.forename: Amol
authors.initials: A
authors.lastname: Takalkar
authors.affiliation: Department of Radiology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
authors.forename: Wengen
authors.initials: W
authors.lastname: Chen
authors.affiliation: Department of Radiology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
authors.forename: Benoit
authors.initials: B
authors.lastname: Desjardins
authors.affiliation: Department of Radiology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
authors.forename: Abass
authors.initials: A
authors.lastname: Alavi
authors.affiliation: Department of Radiology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
authors.forename: Drew A
authors.initials: DA
authors.lastname: Torigian
keywords: Cardiac CT; Cardiac MR; Cardiac PET; FDG; Myocardial viability